scispace - formally typeset
G

Gary Burgess

Researcher at Pfizer

Publications -  17
Citations -  3275

Gary Burgess is an academic researcher from Pfizer. The author has contributed to research in topics: Sildenafil & Liver transplantation. The author has an hindex of 8, co-authored 16 publications receiving 3082 citations.

Papers
More filters
Journal ArticleDOI

Sildenafil citrate therapy for pulmonary arterial hypertension.

TL;DR: Among the 222 patients completing one year of treatment with sildenafil monotherapy, the improvement from baseline at one year in the distance walked in six minutes was 51 m, and the incidence of clinical worsening did not differ significantly between the patients treated with s Bildenafils and those treated with placebo.
Journal Article

Sildenafil for pulmonary arterial hypertension associated with connective tissue disease.

TL;DR: In patients with PAH-CTD, sildenafil improves exercise capacity, hemodynamic measures, and functional class after 12 weeks of treatment.
Journal ArticleDOI

Mutual pharmacokinetic interactions between steady-state bosentan and sildenafil

TL;DR: There is a mutual pharmacokinetic interaction between bosentan and sildenafil that may influence the dosage of each drug in a combination treatment, and further trials in patients with PAH are needed.
Journal ArticleDOI

Digital image analysis of collagen assessment of progression of fibrosis in recurrent HCV after liver transplantation

TL;DR: CPA fibrosis progression rate is a better predictor of clinical outcome than progression by Ishak stage, and histological de novo hepatitis, older donor age and non-use/discontinuation of azathioprine are associated with rapid Fibrosis progression in recurrent HCV chronic hepatitis after liver transplantation.